TY - JOUR
T1 - Effects of recognizing depression with a standardized questionnaire (CES-D) versus patient reporting of depression after a single-standardized question on the outcomes of treatment for hepatitis C with pegylated interferon-α-2b and ribavirin
AU - Phillips, Frances H.
AU - Prebis, Melanie
AU - Grumbeck, Catherine
AU - Hale, Teresa
AU - Cubillas, Raul
AU - Brown, Geri R.
PY - 2010/12
Y1 - 2010/12
N2 - Background: Depression may worsen during antiviral treatment for hepatitis C virus, resulting in noncompliance treatment. AIM: The aim was to compare the response and compliance rates between the groups of veteran patients using two different methods of identifying depression, either the Centers for Epidemiology Studies for Depression Scale (group A) questionnaire or the report of symptoms of depression after a single-standardized question by the health care provider (group B). Methods: One hundred and twenty-nine patients were randomly assigned to the two groups before the treatment. Results: No statistical differences were noted in baseline characteristics between the groups. Depression was common in both the groups. No difference between initial Centers for Epidemiologic Studies Depression Scale scores and diagnosis of depression between the two groups was noted. Furthermore, the number of patients diagnosed with depression during the treatment was similar in each group. There were no significant differences between the groups in rates of sustained viral response (30% group A, 35% group B) or in rates of overall compliance with patients receiving more than 90% of prescribed PegIntronA therapy (44% group A, 39% group B), and ribavirin (32% group A and 37% group B). Conclusion: The use of the Centers for Epidemiology Studies for Depression Scale questionnaire to recognize depression had no significant advantage over patient reporting of depression symptoms after a single-standardized question on the hepatitis C virus clearance and the treatment compliance rates in veteran populations.
AB - Background: Depression may worsen during antiviral treatment for hepatitis C virus, resulting in noncompliance treatment. AIM: The aim was to compare the response and compliance rates between the groups of veteran patients using two different methods of identifying depression, either the Centers for Epidemiology Studies for Depression Scale (group A) questionnaire or the report of symptoms of depression after a single-standardized question by the health care provider (group B). Methods: One hundred and twenty-nine patients were randomly assigned to the two groups before the treatment. Results: No statistical differences were noted in baseline characteristics between the groups. Depression was common in both the groups. No difference between initial Centers for Epidemiologic Studies Depression Scale scores and diagnosis of depression between the two groups was noted. Furthermore, the number of patients diagnosed with depression during the treatment was similar in each group. There were no significant differences between the groups in rates of sustained viral response (30% group A, 35% group B) or in rates of overall compliance with patients receiving more than 90% of prescribed PegIntronA therapy (44% group A, 39% group B), and ribavirin (32% group A and 37% group B). Conclusion: The use of the Centers for Epidemiology Studies for Depression Scale questionnaire to recognize depression had no significant advantage over patient reporting of depression symptoms after a single-standardized question on the hepatitis C virus clearance and the treatment compliance rates in veteran populations.
KW - depression
KW - hepatitis C
KW - pegylated interferon and ribavirin
UR - http://www.scopus.com/inward/record.url?scp=78349307327&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78349307327&partnerID=8YFLogxK
U2 - 10.1097/MEG.0b013e32833eb8c6
DO - 10.1097/MEG.0b013e32833eb8c6
M3 - Article
C2 - 20802340
AN - SCOPUS:78349307327
SN - 0954-691X
VL - 22
SP - 1435
EP - 1442
JO - European Journal of Gastroenterology and Hepatology
JF - European Journal of Gastroenterology and Hepatology
IS - 12
ER -